Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.23.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021 7,053,146        
Balance at Dec. 31, 2021 $ 705 $ 39,513,093 $ (21,986,215) $ 3,236 $ 17,530,819
Issuance of common stock related to restricted stock award (in shares) 10,000        
Issuance of common stock related to restricted stock award $ 1 34,799 0 0 34,800
Comprehensive loss (15,330) (15,330)
Net loss (850,083) (850,083)
Issuance of common stock related to April offering (in shares) 2,229,950        
Issuance of common stock related to April offering $ 223 7,004,815 0 0 7,005,038
Balance (in shares) at Mar. 31, 2022 9,293,096        
Balance at Mar. 31, 2022 $ 929 46,552,707 (22,836,298) (12,094) 23,705,244
Balance (in shares) at Dec. 31, 2021 7,053,146        
Balance at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 17,530,819
Net loss         (2,505,944)
Balance (in shares) at Jun. 30, 2022 9,293,096        
Balance at Jun. 30, 2022 $ 929 47,206,953 (24,492,159) (16,882) 22,698,841
Balance (in shares) at Mar. 31, 2022 9,293,096        
Balance at Mar. 31, 2022 $ 929 46,552,707 (22,836,298) (12,094) 23,705,244
Issuance of common stock related to restricted stock award 0 654,246 0 0 654,246
Comprehensive loss 0 0 0 (4,788) (4,788)
Net loss $ 0 0 (1,655,861) 0 (1,655,861)
Balance (in shares) at Jun. 30, 2022 9,293,096        
Balance at Jun. 30, 2022 $ 929 47,206,953 (24,492,159) (16,882) 22,698,841
Balance (in shares) at Dec. 31, 2022 14,402,025        
Balance at Dec. 31, 2022 $ 1,440 56,963,200 (31,146,804) (40,717) 25,777,119
Issuance of common stock related to restricted stock award (in shares) 39,000        
Issuance of common stock related to restricted stock award $ 4 60,536 0 0 60,540
Comprehensive loss 0 0 0 (22,985) (22,985)
Net loss $ 0 0 (1,187,230) 0 (1,187,230)
Balance (in shares) at Mar. 31, 2023 14,441,025        
Balance at Mar. 31, 2023 $ 1,444 57,023,736 (32,334,034) (63,702) 24,627,444
Balance (in shares) at Dec. 31, 2022 14,402,025        
Balance at Dec. 31, 2022 $ 1,440 56,963,200 (31,146,804) (40,717) 25,777,119
Net loss         (5,527,971)
Balance (in shares) at Jun. 30, 2023 18,699,596        
Balance at Jun. 30, 2023 $ 1,870 65,171,061 (36,674,775) (75,670) 28,422,486
Balance (in shares) at Mar. 31, 2023 14,441,025        
Balance at Mar. 31, 2023 $ 1,444 57,023,736 (32,334,034) (63,702) 24,627,444
Issuance of common stock related to restricted stock award (in shares) 725,000        
Issuance of common stock related to restricted stock award $ 73 1,183,061 0 0 1,183,134
Comprehensive loss 0 0 0 (11,968) (11,968)
Net loss $ 0 0 (4,340,741) 0 (4,340,741)
Issuance of common stock related to April offering (in shares) 3,428,571        
Issuance of common stock related to April offering $ 343 5,999,657 0 0 6,000,000
Issuance of common stock related to exercise of warrants (in shares) 105,000        
Issuance of common stock related to exercise of warrants $ 10 183,740 0 0 183,750
Stock-based compensation in connection with options granted $ 0 780,867 0 0 780,867
Balance (in shares) at Jun. 30, 2023 18,699,596        
Balance at Jun. 30, 2023 $ 1,870 $ 65,171,061 $ (36,674,775) $ (75,670) $ 28,422,486